L3Harris Technologies, Inc. vs Takeda Pharmaceutical Company Limited
時価総額の推移比較
L3Harris Technologies, Inc.
$56.3B
順位 #265
Takeda Pharmaceutical Company Limited
$56.7B
順位 #263
時価総額の推移
主な転換点
- L3Harris Technologies, Inc.が2020年までにTakeda Pharmaceutical Company Limitedを上回った
- Takeda Pharmaceutical Company Limitedが2022年までにL3Harris Technologies, Inc.を上回った
- L3Harris Technologies, Inc.が2025年までにTakeda Pharmaceutical Company Limitedを上回った
- Takeda Pharmaceutical Company Limitedが2026年までにL3Harris Technologies, Inc.を上回った
年次比較
| 年 | L3Harris Technologies, Inc. | Takeda Pharmaceutical Company Limited | 首位 |
|---|---|---|---|
| 2026 | $56.3B | $56.7B | Takeda Pharmaceutical Company Limited |
| 2025 | $54.3B | $50.3B | L3Harris Technologies, Inc. |
| 2024 | $38.1B | $41.6B | Takeda Pharmaceutical Company Limited |
| 2023 | $37.4B | $38.6B | Takeda Pharmaceutical Company Limited |
| 2022 | $36.1B | $37.6B | Takeda Pharmaceutical Company Limited |
| 2021 | $36.3B | $27.3B | L3Harris Technologies, Inc. |
| 2020 | $31.6B | $31.2B | L3Harris Technologies, Inc. |
| 2019 | $32.5B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2018 | $21.8B | $28.0B | Takeda Pharmaceutical Company Limited |
| 2017 | $22.5B | $46.8B | Takeda Pharmaceutical Company Limited |
| 2016 | $16.0B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2015 | $13.2B | $41.4B | Takeda Pharmaceutical Company Limited |
| 2014 | $10.7B | $33.1B | Takeda Pharmaceutical Company Limited |
| 2013 | $10.1B | $30.8B | Takeda Pharmaceutical Company Limited |
| 2012 | $6.9B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2011 | $4.9B | $19.8B | Takeda Pharmaceutical Company Limited |
| 2010 | $6.0B | $22.3B | Takeda Pharmaceutical Company Limited |
| 2009 | $6.2B | $20.5B | Takeda Pharmaceutical Company Limited |
| 2008 | $4.6B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2007 | $7.4B | $32.5B | Takeda Pharmaceutical Company Limited |
| 2006 | $5.4B | $39.6B | Takeda Pharmaceutical Company Limited |
| 2005 | $5.0B | $30.4B | Takeda Pharmaceutical Company Limited |
| 2004 | $3.6B | $24.2B | Takeda Pharmaceutical Company Limited |
| 2003 | $2.2B | $19.6B | Takeda Pharmaceutical Company Limited |
| 2002 | $1.5B | $22.5B | Takeda Pharmaceutical Company Limited |
| 2001 | $1.7B | $26.6B | Takeda Pharmaceutical Company Limited |
| 2000 | $1.7B | $30.0B | Takeda Pharmaceutical Company Limited |